106 related articles for article (PubMed ID: 21054119)
1. Cancer detection by native fluorescence of urine.
Masilamani V; Vijmasi T; Al Salhi M; Govindaraj K; Vijaya-Raghavan AP; Antonisamy B
J Biomed Opt; 2010; 15(5):057003. PubMed ID: 21054119
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence spectra of blood and urine for cervical cancer detection.
Masilamani V; Alsalhi MS; Vijmasi T; Govindarajan K; Rathan Rai R; Atif M; Prasad S; Aldwayyan AS
J Biomed Opt; 2012 Sep; 17(9):98001-1. PubMed ID: 23085927
[TBL] [Abstract][Full Text] [Related]
3. Detection of cancer by optical analysis of body fluids--a single blind study.
Alsalhi M; Masilamani V; Trinka V; Elangovan M; Kochupillai V; Shah N
Technol Cancer Res Treat; 2011 Apr; 10(2):145-52. PubMed ID: 21381792
[TBL] [Abstract][Full Text] [Related]
4. A study for the detection of kidney cancer using fluorescence emission spectra and synchronous fluorescence excitation spectra of blood and urine.
Atif M; AlSalhi MS; Devanesan S; Masilamani V; Farhat K; Rabah D
Photodiagnosis Photodyn Ther; 2018 Sep; 23():40-44. PubMed ID: 29800712
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma: A Prospective Cohort Study.
Morrissey JJ; Mellnick VM; Luo J; Siegel MJ; Figenshau RS; Bhayani S; Kharasch ED
JAMA Oncol; 2015 May; 1(2):204-12. PubMed ID: 26181025
[TBL] [Abstract][Full Text] [Related]
6. Update on urine as a biomarker in cancer: a necessary review of an old story.
Zhang W; Zhang XJ; Chao SY; Chen SJ; Zhang ZJ; Zhao J; Lv YN; Yao JJ; Bai YY
Expert Rev Mol Diagn; 2020 May; 20(5):477-488. PubMed ID: 32212972
[No Abstract] [Full Text] [Related]
7. Steady-state and time-resolved fluorescence spectroscopic characterization of urine of healthy subjects and cervical cancer patients.
Rajasekaran R; Aruna PR; Koteeswaran D; Bharanidharan G; Baludavid M; Ganesan S
J Biomed Opt; 2014 Mar; 19(3):37003. PubMed ID: 24647974
[TBL] [Abstract][Full Text] [Related]
8. Zinc α2-glycoprotein as a potential novel urine biomarker for the early diagnosis of prostate cancer.
Katafigiotis I; Tyritzis SI; Stravodimos KG; Alamanis C; Pavlakis K; Vlahou A; Makridakis M; Katafigioti A; Garbis SD; Constantinides CA
BJU Int; 2012 Dec; 110(11 Pt B):E688-93. PubMed ID: 23020913
[TBL] [Abstract][Full Text] [Related]
9. Cervical cancer detection by time-resolved spectra of blood components.
Kalaivani R; Masilamani V; AlSalhi MS; Devanesan S; Ramamurthy P; Palled SR; Ganesh KM
J Biomed Opt; 2014 May; 19(5):057011. PubMed ID: 24853147
[TBL] [Abstract][Full Text] [Related]
10. Accuracy evaluation of the C. elegans cancer test (N-NOSE) using a new combined method.
Inaba S; Shimozono N; Yabuki H; Enomoto M; Morishita M; Hirotsu T; di Luccio E
Cancer Treat Res Commun; 2021; 27():100370. PubMed ID: 33901923
[TBL] [Abstract][Full Text] [Related]
11. Characterization and diagnosis of cancer by native fluorescence spectroscopy of human urine.
Rajasekaran R; Aruna PR; Koteeswaran D; Padmanabhan L; Muthuvelu K; Rai RR; Thamilkumar P; Murali Krishna C; Ganesan S
Photochem Photobiol; 2013; 89(2):483-91. PubMed ID: 22971002
[TBL] [Abstract][Full Text] [Related]
12. Gene expression test for the non-invasive diagnosis of bladder cancer: A prospective, blinded, international and multicenter validation study.
Ribal MJ; Mengual L; Lozano JJ; Ingelmo-Torres M; Palou J; Rodríguez-Faba O; Witjes JA; Van der Heijden AG; Medina R; Conde JM; Marberger M; Schmidbauer J; Fernández PL; Alcaraz A
Eur J Cancer; 2016 Feb; 54():131-138. PubMed ID: 26761785
[TBL] [Abstract][Full Text] [Related]
13. Increased accuracy of a novel mRNA-based urine test for bladder cancer surveillance.
Pichler R; Fritz J; Tulchiner G; Klinglmair G; Soleiman A; Horninger W; Klocker H; Heidegger I
BJU Int; 2018 Jan; 121(1):29-37. PubMed ID: 28941000
[TBL] [Abstract][Full Text] [Related]
14. Relevance of urine telomerase in the diagnosis of bladder cancer.
Sanchini MA; Gunelli R; Nanni O; Bravaccini S; Fabbri C; Sermasi A; Bercovich E; Ravaioli A; Amadori D; Calistri D
JAMA; 2005 Oct; 294(16):2052-6. PubMed ID: 16249419
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive Diagnosis of Pancreatic Cancer Through Detection of Volatile Organic Compounds in Urine.
Arasaradnam RP; Wicaksono A; O'Brien H; Kocher HM; Covington JA; Crnogorac-Jurcevic T
Gastroenterology; 2018 Feb; 154(3):485-487.e1. PubMed ID: 29129714
[No Abstract] [Full Text] [Related]
16. Comparison of the sensitivity and specificity of urine cytology, urinary nuclear matrix protein-22 and multitarget fluorescence in situ hybridization assay in the detection of bladder cancer.
Kehinde EO; Al-Mulla F; Kapila K; Anim JT
Scand J Urol Nephrol; 2011 Mar; 45(2):113-21. PubMed ID: 21091091
[TBL] [Abstract][Full Text] [Related]
17. A Novel Approach of Urinary Monohydroxyphenyl Metabolites Assay in Cancer Screening.
Gan C; Yao LQ; Su N; Zhu JH; Li F; Li WT; Wang YY; Shi YX; Yu HT
Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710433
[TBL] [Abstract][Full Text] [Related]
18. MALBAC-based chromosomal imbalance analysis: a novel technique enabling effective non-invasive diagnosis and monitoring of bladder cancer.
Liu H; He W; Wang B; Xu K; Han J; Zheng J; Ren J; Shao L; Bo S; Lu S; Lin T; Huang J
BMC Cancer; 2018 Jun; 18(1):659. PubMed ID: 29907142
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the nuclear matrix protein 22 with voided urine cytology and BTA stat test in the diagnosis of transitional cell carcinoma of the bladder.
Sözen S; Biri H; Sinik Z; Küpeli B; Alkibay T; Bozkirli I
Eur Urol; 1999 Sep; 36(3):225-9. PubMed ID: 10450007
[TBL] [Abstract][Full Text] [Related]
20. Comparison of telomerase activity and matrix metalloproteinase-9 in voided urine and bladder wash samples as a useful diagnostic tool for bladder cancer.
Eissa S; Labib RA; Mourad MS; Kamel K; El-Ahmady O
Eur Urol; 2003 Dec; 44(6):687-94. PubMed ID: 14644121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
